An α2C-adrenergic receptor polymorphism alters the norepinephrine-lowering effects and therapeutic response of the β-Blocker Bucindolol in chronic heart failure

Michael R. Bristow, Guinevere A. Murphy, Heidi Krause-Steinrauf, Jeffrey L. Anderson, John F. Carlquist, Surai Thaneemit-Chen, Vaishali Krishnan, William T. Abraham, Brian D. Lowes, J. David Port, Gordon W. Davis, Laura C. Lazzeroni, Alastair D. Robertson, Phillip W. Lavori, Stephen B. Liggett

Research output: Contribution to journalArticlepeer-review

91 Scopus citations

Fingerprint Dive into the research topics of 'An α<sub>2C</sub>-adrenergic receptor polymorphism alters the norepinephrine-lowering effects and therapeutic response of the β-Blocker Bucindolol in chronic heart failure'. Together they form a unique fingerprint.

Medicine & Life Sciences